RT Journal Article
SR Electronic
T1 Alzheimer’s disease variant portal (ADVP): a catalog of genetic findings for Alzheimer’s disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.29.20203950
DO 10.1101/2020.09.29.20203950
A1 Kuksa, Pavel P.
A1 Liu, Chia-Lun
A1 Fu, Wei
A1 Qu, Liming
A1 Zhao, Yi
A1 Katanic, Zivadin
A1 Kuzma, Amanda B
A1 Ho, Pei-Chuan
A1 Tzeng, Kai-Teh
A1 Valladares, Otto
A1 Chou, Shin-Yi
A1 Naj, Adam C
A1 Schellenberg, Gerard D
A1 Wang, Li-San
A1 Leung, Yuk Yee
YR 2020
UL http://medrxiv.org/content/early/2020/09/30/2020.09.29.20203950.abstract
AB Background Alzheimer’s disease (AD) genetic findings span progressively larger genome-wide association studies (GWASs) for various outcomes and populations. These genetic findings are obtained from a single GWAS, joint- or meta-analyses of multiple GWAS datasets. However, no single resource provides harmonized and searchable information on all AD genetic associations obtained from these analyses, nor linking the identified genetic variants and reported genes with other supporting functional genomic evidence.Methods We created the Alzheimer’s Disease Variant Portal (ADVP), which provides unified access to a uniquely extensive collection of high-quality GWAS association results for AD. Records in ADVP are curated from the genome-wide significant and suggestive loci reported in AD genetics literature. ADVP contains curated results from all AD GWAS publications by Alzheimer’s Disease Genetics Consortium (ADGC) since 2009 and AD GWAS publications identified from other public catalogs (GWAS catalog). Genetic association information was systematically extracted from these publications, harmonized, and organized into three types of tables. These tables included structured publication, variant, and association categories to ensure consistent representation of all AD genetic findings. All extracted AD genetic associations were further annotated and integrated with NIAGADS Alzheimer’s Genomics DB in order to provide extensive biological and functional genomics annotations.Results Currently, ADVP contains 6,990 AD-association records curated from >200 AD GWAS publications corresponding to >900 unique genomic loci and >1,800 unique genetic variants. The ADVP collection contains genetic findings from >80 cohorts and across various populations, including Caucasians, Hispanics, African-Americans, and Asians. Of all the association records, 46% are disease-risk, 13% are related to expression quantitative trait analyses, and 27% are related to AD endophenotypes and neuropathology. ADVP web interface allows accessing AD association records by individual variants, genes, publications, genomic regions of interest, and genome-wide interactive variant views. ADVP is integrated with the NIAGADS Alzheimer’s Genomics Database. Researchers can explore additional biological annotations at the genetic variant or gene level and view cross-reference functional genomics evidence provided by other public resources.Conclusions ADVP is the largest, most up-to-date, and comprehensive literature-derived collection of AD genetic associations. All records have been systematically curated, harmonized, and comprehensively annotated. ADVP is freely accessible at https://advp.niagads.org/.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institute on Aging [U24-AG041689, U54-AG052427, U01-AG032984]; Biomarkers Across Neurodegenerative Diseases (BAND 3) (award number 18062), co-funded by Michael J Fox Foundation, Alzheimer's Association, Alzheimer's Research UK and the Weston Brain institute.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available at https://advp.niagads.org.